Accretion Pharmaceuticals SME IPO Details 2026

Incorporated in 2012, Accretion Pharmaceuticals Limited is a pharmaceutical company that manufactures and sells tablets, capsules, and other healthcare products.

The company also offers contract manufacturing services. The Company manufactures and markets Tablets, Capsules, Oral Liquids, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), and Oral Powder (Sachet, Dry Syrup).

The company also holds ISO 9001:2015, ISO 14001:2015, and ISO 22000:2005 certifications, reflecting its dedication to quality and environmental management systems.

The company's manufacturing unit is located in Ahmedabad, Sanand, Gujarat.

The company has expanded its global footprint, marking its presence in more than 20 countries, including regions in Africa, Southeast Asia, and the Middle East.

Product Portfolio and Services

• Tablets and Capsules – Covering antibiotics, anti-inflammatory, pain management, cardiovascular, and gastrointestinal medicines.
• Oral Liquids and Syrups – Used for respiratory, pediatric, and digestive treatments.
• External Preparations – Including medicated lotions, gels, ointments, and dusting powders for skin care and dermatological treatments.
• Ayurvedic and Herbal Products – Focused on natural wellness solutions for immunity, digestion, and general health.

As of January 2025, the company has 83 employees (including 4 Executive Directors) on its payroll.

Competitive Strength:

• Experienced Promoters and Management Team.
• Long-standing relationship with clients and suppliers.
• Focus on providing quality products.
• Management has built a supply chain and customer relations, creating goodwill and trust.